Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 232 of 1,261
  1. US 11472884

    Humanized BCMA antibody and BCMA-CAR-T cells

    Caribou Biosciences, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  2. US 11472875

    Matrix metalloprotease-cleavable and serine protease-cleavable substrates and methods of use thereof

    CytomX Therapeutics, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  3. US 11472881

    Single-domain antibodies and variants thereof against CTLA-4

    Nanjing Legend Biotech Co., Ltd · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  4. US 11472789

    Bicyclic carboxamides and methods of use thereof

    TEMPEST THERAPEUTICS, INC. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  5. US 11472840

    Acetylcholine receptor-binding peptide

    SKINMED CO., LTD. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  6. US 11472804

    Compositions and methods for modulating hair growth

    The Regents of the University of California · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  7. US 11472813

    OX2R compounds

    The Board of Regents of the University of Texas System · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  8. US 11472842

    Analogues of hepcidin mimetics with improved in vivo half lives

    Protagonist Therapeutics, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  9. US 11472812

    Anti-cancer compounds targeting Ral GTPases and methods of using the same

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  10. US 11472808

    Substituted pyrrolo[1,2-c]pyrimidines as hepatitis B antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  11. US 11472861

    Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  12. US 11471517

    Compositions and methods for preventing and treating graft versus host disease

    Regents of the University of Minnesota · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  13. US 11471528

    Methods for using extracellular adenosine inhibitors and adenosine receptor inhibitors to enhance immune response and inflammation

    The Government of the United States of America as represented by the Secretary of the Department · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  14. US 11472888

    Reelin antibodies for treatment of atherosclerosis

    The Board of Regents of the University of Texas System · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  15. US 11471534

    Chitosan-pluronic complex and nano-carrier comprising same

    SKINMED CO., LTD. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  16. US 11472729

    Silicate glass and dental product

    KURARAY NORITAKE DENTAL INC. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  17. US 11471464

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  18. US 11471465

    Pharmaceutical compositions comprising meloxicam

    AXSOME THERAPEUTICS, INC. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  19. US 11471496

    Compositions and methods for treating or ameliorating cocaine addiction

    The Regents of the University of Colorado · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  20. US 11471448

    Sphingosine kinase 2 inhibitor for treating coronavirus infection in moderately severe patients with pneumonia

    RedHill Biopharma Ltd. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  21. US 11471502

    Neuroprotective peptide

    University College Cardiff Consultants Limited · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  22. US 11471471

    Aqueous oral pharmaceutical suspension compositions

    ReveraGen BioPharma, Inc. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  23. US 11471449

    Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

    The Board of Regents of the University of Texas System · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted
  24. US 11472772

    S1P3 antagonists

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Oct 18, 2022 · Expires Oct 13, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.